L-147-2023

Agreement ID
L-147-2023
Lead IC
NIAID
Exclusivity
Exclusive
External Party
Teraimmune Inc.
Fiscal Year
2023
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-2481     A Method to Expand a Population of Regulatory T Cells Optimal for the Treatment of Autoimmune Diseases